Buprenorphine Use in Palliative Care.

Buprenorphine Use in Palliative Care.

Publication date: Dec 01, 2019

Palliative care is encountering an increasing number of patients with opioid use disorder who are managed on medication-assisted treatment. Buprenorphine is US Food and Drug Administration approved for office-based management of opioid use disorder. As a partial opioid agonist, it can be used to manage pain in the palliative care setting but can also pose inherent challenges to the management of pain that necessitates full opioid agonists. This article uses a case example to highlight the management of substance use disorder and pain in a patient on buprenorphine along the full illness trajectory. In addition, an overview of buprenorphine pharmacology, unique aspects of the prescribing waiver, and pain management will be discussed.

Jones, K.F. Buprenorphine Use in Palliative Care. 04301. 2019 J Hosp Palliat Nurs (21):6.

Concepts Keywords
Agonist Buprenorphine/naloxone
Buprenorphine Opioid-induced hyperalgesia
Opioid Ethers
Pain Buprenorphine
Pain Management Opioid antagonists
Palliative Care Drug rehabilitation
Pharmacology RTT
Analgesics
Morphinans
Drugs
Opioids
Pain management
Pain
Opioid disorder
Patient buprenorphine illness
Waiver pain management

Semantics

Type Source Name
disease MESH substance use disorder
drug DRUGBANK Buprenorphine

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *